Clinical Trial Update: A Study of AK138D1 in Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of AK138D1 in advanced malignant tumors (solid cancers) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AK138D1

Snippet

Sponsor: Akeso | Conditions: Solid Cancer | Phase 1 | Status: RECRUITING